128 related articles for article (PubMed ID: 34720664)
1. The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting.
Hagenmaier HSF; van Beeck AGK; Haas RL; van Praag VM; van Bodegom-Vos L; van der Hage JA; Krol S; Speetjens FM; Cleven AHG; Navas A; Kroon HM; Moeri-Schimmel RG; Leyerzapf NAC; van de Sande MAJ
Sarcoma; 2021; 2021():8851354. PubMed ID: 34720664
[TBL] [Abstract][Full Text] [Related]
2. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).
van Praag VM; Rueten-Budde AJ; Jeys LM; Laitinen MK; Pollock R; Aston W; van der Hage JA; Dijkstra PDS; Ferguson PC; Griffin AM; Willeumier JJ; Wunder JS; van de Sande MAJ; Fiocco M
Eur J Cancer; 2017 Sep; 83():313-323. PubMed ID: 28797949
[TBL] [Abstract][Full Text] [Related]
3. The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.
Acem I; van Houdt WJ; Grünhagen DJ; van der Graaf WTA; Rueten-Budde AJ; Gelderblom H; Verhoef C; ; van de Sande MAJ
Eur J Cancer; 2022 Apr; 165():71-80. PubMed ID: 35219025
[TBL] [Abstract][Full Text] [Related]
4. (Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).
Kruiswijk AA; van de Sande MAJ; Haas RL; van den Akker-van Marle EM; Engelhardt EG; Marang-van de Mheen P; van Bodegom-Vos L;
BMJ Open; 2023 Nov; 13(11):e074853. PubMed ID: 37918933
[TBL] [Abstract][Full Text] [Related]
5. Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly.
Bleckman RF; Acem I; van Praag VM; Dorleijn DMJ; Verhoef C; Schrage YM; Haas RML; van de Sande MAJ; The Collaborative Persarc Research Group ;
Eur J Surg Oncol; 2022 May; 48(5):985-993. PubMed ID: 34930647
[TBL] [Abstract][Full Text] [Related]
6. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma.
Rueten-Budde AJ; van Praag VM; van de Sande MAJ; Fiocco M;
J Surg Oncol; 2021 Mar; 123(4):1050-1056. PubMed ID: 33332599
[TBL] [Abstract][Full Text] [Related]
7. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.
Ung KA; Campbell BA; Duplan D; Ball D; David S
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e298-304. PubMed ID: 24674013
[TBL] [Abstract][Full Text] [Related]
8. Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Smolle MA; Sande MV; Callegaro D; Wunder J; Hayes A; Leitner L; Bergovec M; Tunn PU; van Praag V; Fiocco M; Panotopoulos J; Willegger M; Windhager R; Dijkstra SPD; van Houdt WJ; Riedl JM; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Smolle J; Andreou D; Leithner A; Gronchi A; Haas RL; Szkandera J
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877801
[TBL] [Abstract][Full Text] [Related]
9. The multidisciplinary colposcopy meeting: recommendations for future service provision and an analysis of clinical decision making.
Palmer JE; Wales K; Ellis K; Dudding N; Smith J; Tidy JA
BJOG; 2010 Aug; 117(9):1060-6. PubMed ID: 20604774
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer management at an Italian tertiary referral center: does multidisciplinary team meeting influence diagnostic and therapeutic decision-making process? A snapshot of the everyday clinical practice.
De Luca S; Fiori C; Tucci M; Poggio M; Allis S; Bollito E; Solitro F; Passera R; Buttigliero C; Porpiglia F
Minerva Urol Nefrol; 2019 Dec; 71(6):576-582. PubMed ID: 31487974
[TBL] [Abstract][Full Text] [Related]
11. Is there a Benefit of Multidisciplinary Cancer Team Meetings for Patients with Gastrointestinal Malignancies?
Basta YL; Baur OL; van Dieren S; Klinkenbijl JH; Fockens P; Tytgat KM
Ann Surg Oncol; 2016 Aug; 23(8):2430-7. PubMed ID: 27002814
[TBL] [Abstract][Full Text] [Related]
12. Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer.
Jung SM; Hong YS; Kim TW; Park JH; Kim JH; Park SH; Kim AY; Lim SB; Lee YJ; Yu CS
World J Surg; 2018 Jul; 42(7):2227-2233. PubMed ID: 29282505
[TBL] [Abstract][Full Text] [Related]
13. Degrees of Multidisciplinarity Underpinning Care Planning for Patients with Cancer in Weekly Multidisciplinary Team Meetings: Conversation Analysis.
Soukup T; Murtagh G; Lamb BW; Green JSA; Sevdalis N
J Multidiscip Healthc; 2021; 14():411-424. PubMed ID: 33633452
[TBL] [Abstract][Full Text] [Related]
14. [Multidisciplinary team meetings in cancerology: setting priorities for improvement].
Guillem P; Bolla M; Courby S; Descotes JL; Laramas M; Moro-Sibilot D
Bull Cancer; 2011 Oct; 98(9):989-98. PubMed ID: 21908262
[TBL] [Abstract][Full Text] [Related]
15. The role of multidisciplinary decision making in oropharyngeal cancer: do we follow guidelines and are treatment decisions being implemented?
Ghazal Asswad R; Alvi S; Davies K; Jones TM; Hamilton DW; Brammer C; Lancaster J; Loh C; Tandon S; Roland N
Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):947-952. PubMed ID: 31915919
[TBL] [Abstract][Full Text] [Related]
16. Compliance with a multidisciplinary team meeting's decision prior to bariatric surgery protects against major postoperative complications.
Rebibo L; Maréchal V; De Lameth I; Dhahri A; Escoffier I; Lalau JD; Regimbeau JM
Surg Obes Relat Dis; 2017 Sep; 13(9):1537-1543. PubMed ID: 28705572
[TBL] [Abstract][Full Text] [Related]
17. Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change.
Rankin NM; Lai M; Miller D; Beale P; Spigelman A; Prest G; Turley K; Simes J
Asia Pac J Clin Oncol; 2018 Feb; 14(1):74-83. PubMed ID: 28949100
[TBL] [Abstract][Full Text] [Related]
18. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Pillay B; Wootten AC; Crowe H; Corcoran N; Tran B; Bowden P; Crowe J; Costello AJ
Cancer Treat Rev; 2016 Jan; 42():56-72. PubMed ID: 26643552
[TBL] [Abstract][Full Text] [Related]
19. Not all patients need to be discussed in a colorectal cancer MDT meeting.
Ryan J; Faragher I
Colorectal Dis; 2014 Jul; 16(7):520-6. PubMed ID: 24617857
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
